Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...
Morning Overview on MSN
Pfizer and BioNTech pause US COVID vaccine trial after slow enrollment
Pfizer and BioNTech have paused a large U.S. clinical trial designed to test their updated COVID-19 vaccine in healthy adults ...
By partnering with other like-minded organizations to fund targeted RFAs throughout the year, ACS is able to invest in new ...
In the world of clinical trials, missing the primary endpoint of a pivotal trial typically spells real trouble for a drug ...
Pfizer (PFE) stock and BioNTech (BNTX) stock are in focus as a large U.S. trial for the companies' updated COVID-19 vaccine ...
The trial is tied to a post-marketing commitment that FDA Commissioner Martin Makary put in place last year for all approved ...
The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic ...
Learn how pharma company Pfizer makes money through prescription drugs, vaccines, oncology treatments, and global ...
Prestigious international award recognizes landmark discoveries in biomedical and global health research. TORONTO, March 31, 2026 /CNW/ - The Gairdner Foundation today announced the nine 2026 Canada ...
Adults with moderate to severe hidradenitis suppurativa experienced substantial long-term symptom relief and quality of life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results